Related Experiment Video

Updated: Jul 28, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Paclitaxel rechallenge failure after a major hypersensitivity reaction

M S Laskin, K J Lucchesi, M Morgan

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |December 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

    Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

    Published on: May 14, 2018

    In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function08:04

    In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

    Published on: February 27, 2019

    Related Concept Videos

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

    Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...